While the correlation between CHI3L1(YKL40) expression and COPD has been observed, further research is needed to elucidate the underlying mechanisms of CHI3L1(YKL40) in COPD pathogenesis and its potential as a therapeutic target for this complex lung disease. Here, CHI3L1 is linked to lung disorder.